Stockscreener 앱 받기
10.73
2.45%
-0.27
시간 외 거래:
10.59
-0.14
-1.30%
전일 마감가:
$11.00
열려 있는:
$10.98
하루 거래량:
1.92M
Relative Volume:
0.60
시가총액:
$837.57M
수익:
$65,400
순이익/손실:
$-46.34M
주가수익비율:
-11.66
EPS:
-0.92
순현금흐름:
$-38.74M
1주 성능:
-5.38%
1개월 성능:
-16.11%
6개월 성능:
+56.87%
1년 성능:
+10.28%
1일 변동 폭
$10.55
$11.06
1주일 범위
$10.55
$11.71
52주 변동 폭
$5.60
$17.43
CorMedix Inc Stock (CRMD) Company Profile
명칭
CorMedix Inc
전화
908-517-9500
주소
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
CRMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRMD
CorMedix Inc
|
10.73 | 858.65M | 65,400 | -46.34M | -38.74M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-30 | 다운그레이드 | D. Boral Capital | Buy → Hold |
| 2025-06-30 | 개시 | H.C. Wainwright | Buy |
| 2025-03-07 | 개시 | Leerink Partners | Outperform |
| 2025-01-13 | 개시 | D. Boral Capital | Buy |
| 2024-08-26 | 개시 | Rodman & Renshaw | Buy |
| 2023-08-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-02-17 | 개시 | Needham | Buy |
| 2020-09-29 | 개시 | JMP Securities | Mkt Outperform |
| 2020-09-21 | 개시 | Truist | Buy |
| 2019-12-18 | 개시 | B. Riley FBR | Buy |
| 2019-03-26 | 재확인 | H.C. Wainwright | Buy |
| 2018-12-06 | 개시 | ROTH Capital | Buy |
| 2017-09-25 | 재확인 | H.C. Wainwright | Buy |
| 2017-08-10 | 재확인 | Rodman & Renshaw | Buy |
| 2017-05-05 | 재확인 | Rodman & Renshaw | Buy |
| 2016-11-11 | 재확인 | FBR & Co. | Outperform |
| 2016-03-17 | 재확인 | FBR Capital | Outperform |
| 2016-03-03 | 개시 | FBR Capital | Outperform |
| 2015-11-16 | 재확인 | ROTH Capital | Neutral |
| 2015-10-29 | 재확인 | ROTH Capital | Neutral |
| 2015-05-06 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2014-12-08 | 재확인 | ROTH Capital | Buy |
| 2011-10-03 | 다운그레이드 | Maxim Group | Buy → Hold |
모두보기
CorMedix Inc 주식(CRMD)의 최신 뉴스
Is CorMedix Inc. stock reversal real or fakeWeekly Market Report & Capital Efficiency Focused Ideas - newser.com
Backtesting results for CorMedix Inc. trading strategiesJuly 2025 Drop Watch & Accurate Intraday Trading Signals - newser.com
CorMedix: Challenging Long-Term Risk-Reward, Maintain Sell - Seeking Alpha
Analyzing recovery setups for CorMedix Inc. investorsEntry Point & Fast Moving Market Watchlists - newser.com
Is CorMedix Inc. a candidate for recovery play2025 Historical Comparison & Consistent Growth Stock Picks - newser.com
Risk adjusted return profile for CorMedix Inc. analyzedJuly 2025 Spike Watch & Safe Entry Point Identification - newser.com
Will CorMedix's DefenCath Edge Last If Bigger Heparin Rivals Close In? - Yahoo Finance
How cyclical is CorMedix Inc. (19KA) stock compared to rivalsJobs Report & Verified Swing Trading Watchlist - newser.com
Why CorMedix Inc. stock is in analyst buy zone2025 Institutional Moves & Consistent Profit Trade Alerts - newser.com
CorMedix (CRMD): Assessing Valuation Following Phase III REZZAYO Trial Enrollment and Melinta Growth Moves - Sahm
What analysts say about CorMedix Inc stockMoving Average Crossovers & Low Cost Market Strategies - earlytimes.in
Is a relief rally coming for CorMedix Inc. holders2025 Earnings Impact & Accurate Intraday Trading Signals - newser.com
Will CorMedix Inc. (19KA) stock benefit from Fed rate cutsJuly 2025 Final Week & Risk Managed Investment Signals - newser.com
ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves - The Globe and Mail
CorMedix (CRMD): Assessing Valuation After Recent Volatility and Analyst Price Targets - Yahoo Finance
What macro factors could drive CorMedix Inc. (19KA) stock higherJuly 2025 Weekly Recap & Free Daily Entry Point Trade Alerts - newser.com
Is it too late to sell CorMedix Inc.Trade Signal Summary & Expert Verified Stock Movement Alerts - newser.com
Real time scanner hits for CorMedix Inc. explainedCEO Change & Free Community Consensus Stock Picks - newser.com
Is CorMedix Inc. building a consolidation baseDividend Hike & Smart Allocation Stock Reports - newser.com
CorMedix files to sell 6.32M shares of common stock for holders - MSN
CorMedix Bets Big On Melinta In $300 Million Deal - Finimize
CorMedix completes enrollment in phase III fungal infection study By Investing.com - Investing.com Nigeria
Cormedix announces completion of enrollment in phase III Respect clinical trial for Rezzayo - MarketScreener
CorMedix completes enrollment in phase III fungal infection study - Investing.com
Cormedix Announces Completion Of Enrollment In Phase Iii Respect Clinical Trial For Rezzayo - TradingView
CorMedix Inc. Completes Enrollment in Phase III ReSPECT Study for REZZAYO® in Fungal Infection Prophylaxis, Topline Results Expected 2Q 2026 - Quiver Quantitative
CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO - Yahoo Finance
Major Clinical Trial Progress: CorMedix's REZZAYO Could Transform Blood and Marrow Transplant Care - Stock Titan
What drives CorMedix Inc stock priceSector ETF Performance & Unlock Smart Investment Tactics That Work - earlytimes.in
CorMedix Inc (CRMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.74%
자본화:
|
볼륨(24시간):